tirzepatide while ttc and Pregnancy GLP-1s (Ozempic/Wegovy/Mounjaro/Zepbound, etc.) + TTC:

Learn it, and you will never need to depend on a chart alone

For type 2 diabetes, there are several other medications available that work in different ways to help control blood sugar levels

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity

Retatrutide produces greater weight loss at every comparable timepoint, despite using a lower maximum dose (12 mg versus 15 mg)

Data extraction To ensure the accuracy and reliability of the data, two independent reviewers (YS and JX) performed data extraction for each eligible study based on the pre-specified inclusion and exclusion criteria